If the BALANCE Model launches in some future year with at least 80% participation, Part D plans could drop out of the model before the final year (originally 2031), which could interrupt treatment, or require frequent plan changes for Medicare Part D enrollees to maintain access
Targeting the oxidative stress response system of fungi with redox-potent chemosensitizing agents
Also, the inclusion of the drugs in public drug formularies and expanded insurance coverage for chronic condition management escalates accessibility, especially for underserved populations, and is driving the demand and growth of the market
Peptide aggregation has not been assessed in human studies
This synthetic peptide, derived from a natural protein in the stomach, has been studied for its potential in tissue repair, inflammation control, and cell protection